Protocol for a Pilot Randomized Controlled Trial of a Mobile Health Exercise Intervention for Older Patients with Myeloid Neoplasms (GO-EXCAP 2)

Overview

Journal J Geriatr Oncol

Publisher Elsevier

Specialty Geriatrics

Date 2021 Dec 24

PMID 34949540

Citations 3

Authors

Kah Poh Loh

Chandrika Sanapala

Michelle Janelsins

Heidi D Klepin

Rebecca Schnall

Eva Culakova

Michael B Sohn

Paula Vertino

Martha Susiarjo

Marielle Jensen-Battaglia

Michael W Becker

Jane Liesveld

Jason H Mendler

Eric Huselton

Po-Ju Lin

Karen Mustian

Affiliations

Soon will be listed here.

Abstract

Introduction: We have shown the Exercise for Cancer Patients (EXCAP) exercise program improved physical function and symptoms and reduced inflammatory markers in patients with cancer. However, adherence to exercise was lower in older adults compared to their younger counterparts. We then leveraged a mobile app to deliver EXCAP and adapted the intervention [Geriatric-Oncology (GO)-EXCAP] for older patients with myeloid neoplasms. In this pilot randomized trial, the primary goal is to determine effect sizes. We propose to assess the preliminary efficacy of GO-EXCAP compared to a behavioral placebo control on physical function, patient-reported outcomes (fatigue, mood, and quality of life), and inflammatory markers in 100 patients aged ≥60 years with myeloid neoplasms receiving outpatient chemotherapy.

Methods: GO-EXCAP consists of the EXCAP exercise prescription (daily home-based progressive aerobic walking and resistance exercises with rated perceived exercise of 5-8), EXCAP kit (i.e., activity tracker, resistance bands, print manual, bag), a mobile app, and an in-person or virtual session with the exercise physiologist to deliver exercise prescription. The intervention will last for three cycles of chemotherapy (approximately 12 weeks). The primary outcome measure will be physical function (Short Physical Performance Battery). Secondary outcome measures include fatigue (Brief Fatigue Inventory), mood (Center for Epidemiologic Studies Depression Scale), and quality of life (Functional Assessment of Cancer Therapy-Leukemia). Exploratory outcome measures include inflammatory markers.

Discussion: Older adults with myeloid neoplasms receiving outpatient chemotherapy serve as an ideal model for studying an individually tailored mobile health exercise intervention in vulnerable older patients receiving cancer treatments to prevent physical function decline and improve symptoms.

Citing Articles

Changes in muscle performance among older adults with myeloid malignancies engaging in a mobile health (mHealth) exercise intervention: a single arm pilot study.

Jensen-Battaglia M, Lin P, Sanapala C, Watson E, Mendler J, Liesveld J BMC Geriatr. 2025; 25(1):22.

PMID: 39789445 PMC: 11715464. DOI: 10.1186/s12877-024-05668-w.

Digitizing Survivorship Care Plans Through the POST-Treatment Health Outcomes of Cancer Survivors (POSTHOC) Mobile App: Protocol for a Phase II Randomized Controlled Trial.

Chung K, Youngblood S, Clingan C, Deighton D, Jump V, Manuweera T JMIR Res Protoc. 2024; 13:e59222.

PMID: 39235855 PMC: 11413545. DOI: 10.2196/59222.

An initiative to implement a triage and referral system to make exercise and rehabilitation referrals standard of care in oncology.

Schmitz K, Chongaway A, Saeed A, Fontana T, Wood K, Gibson S Support Care Cancer. 2024; 32(4):259.

PMID: 38561546 PMC: 10984878. DOI: 10.1007/s00520-024-08457-8.

In-person and virtual assessment of short physical performance battery test in older adults with myeloid malignancies.

Sanapala C, Jensen-Battaglia M, Watson E, Konatham S, LoCastro M, Wang Y Blood Adv. 2023; 7(16):4414-4417.

PMID: 36790922 PMC: 10440456. DOI: 10.1182/bloodadvances.2022009396.

References

Smith L, Leo M, Anderson C, Wright T, Weymann K, Wood L . The role of IL-1β and TNF-α signaling in the genesis of cancer treatment related symptoms (CTRS): a study using cytokine receptor-deficient mice. Brain Behav Immun. 2014; 38:66-76. PMC: 3989411. DOI: 10.1016/j.bbi.2013.12.022. View

Campion J, Milagro F, Goyenechea E, Martinez J . TNF-alpha promoter methylation as a predictive biomarker for weight-loss response. Obesity (Silver Spring). 2009; 17(6):1293-7. DOI: 10.1038/oby.2008.679. View

Radom-Aizik S, Zaldivar Jr F, Haddad F, Cooper D . Impact of brief exercise on circulating monocyte gene and microRNA expression: implications for atherosclerotic vascular disease. Brain Behav Immun. 2014; 39:121-9. PMC: 4101903. DOI: 10.1016/j.bbi.2014.01.003. View

Kraemer H, Kiernan M, Essex M, Kupfer D . How and why criteria defining moderators and mediators differ between the Baron & Kenny and MacArthur approaches. Health Psychol. 2008; 27(2S):S101-8. PMC: 3376898. DOI: 10.1037/0278-6133.27.2(Suppl.).S101. View

Brown J, Harhay M, Harhay M . Physical function as a prognostic biomarker among cancer survivors. Br J Cancer. 2014; 112(1):194-8. PMC: 4453612. DOI: 10.1038/bjc.2014.568. View

Leek J, Johnson W, Parker H, Jaffe A, Storey J . The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012; 28(6):882-3. PMC: 3307112. DOI: 10.1093/bioinformatics/bts034. View

Mustian K, Peppone L, Darling T, Palesh O, Heckler C, Morrow G . A 4-week home-based aerobic and resistance exercise program during radiation therapy: a pilot randomized clinical trial. J Support Oncol. 2009; 7(5):158-67. PMC: 3034389. View

Uddin M, Koenen K, Aiello A, Wildman D, de los Santos R, Galea S . Epigenetic and inflammatory marker profiles associated with depression in a community-based epidemiologic sample. Psychol Med. 2010; 41(5):997-1007. PMC: 3065166. DOI: 10.1017/S0033291710001674. View

Rubinstein L, Korn E, Freidlin B, Hunsberger S, Ivy S, Smith M . Design issues of randomized phase II trials and a proposal for phase II screening trials. J Clin Oncol. 2005; 23(28):7199-206. DOI: 10.1200/JCO.2005.01.149. View

10.

Borm G, Fransen J, Lemmens W . A simple sample size formula for analysis of covariance in randomized clinical trials. J Clin Epidemiol. 2007; 60(12):1234-8. DOI: 10.1016/j.jclinepi.2007.02.006. View

11.

Egerton T, Chastin S, Stensvold D, Helbostad J . Fatigue May Contribute to Reduced Physical Activity Among Older People: An Observational Study. J Gerontol A Biol Sci Med Sci. 2015; 71(5):670-6. DOI: 10.1093/gerona/glv150. View

12.

Mandrekar S, Sargent D . Randomized phase II trials: time for a new era in clinical trial design. J Thorac Oncol. 2010; 5(7):932-4. PMC: 2941394. DOI: 10.1097/JTO.0b013e3181e2eadf. View

13.

Sajid S, Dale W, Mustian K, Kotwal A, Heckler C, Porto M . Novel physical activity interventions for older patients with prostate cancer on hormone therapy: A pilot randomized study. J Geriatr Oncol. 2016; 7(2):71-80. PMC: 4818675. DOI: 10.1016/j.jgo.2016.02.002. View

14.

Loh K, Ramsdale E, Culakova E, Mendler J, Liesveld J, ODwyer K . Novel mHealth App to Deliver Geriatric Assessment-Driven Interventions for Older Adults With Cancer: Pilot Feasibility and Usability Study. JMIR Cancer. 2018; 4(2):e10296. PMC: 6234352. DOI: 10.2196/10296. View

15.

Alibhai S, ONeill S, Fisher-Schlombs K, Breunis H, Brandwein J, Timilshina N . A clinical trial of supervised exercise for adult inpatients with acute myeloid leukemia (AML) undergoing induction chemotherapy. Leuk Res. 2012; 36(10):1255-61. PMC: 3767429. DOI: 10.1016/j.leukres.2012.05.016. View

16.

Aryee M, Jaffe A, Corrada-Bravo H, Ladd-Acosta C, Feinberg A, Hansen K . Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014; 30(10):1363-9. PMC: 4016708. DOI: 10.1093/bioinformatics/btu049. View

17.

Courneya K, Segal R, Reid R, Jones L, Malone S, Venner P . Three independent factors predicted adherence in a randomized controlled trial of resistance exercise training among prostate cancer survivors. J Clin Epidemiol. 2004; 57(6):571-9. DOI: 10.1016/j.jclinepi.2003.11.010. View

18.

Craft L, Vaniterson E, Helenowski I, Rademaker A, Courneya K . Exercise effects on depressive symptoms in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2011; 21(1):3-19. PMC: 3253916. DOI: 10.1158/1055-9965.EPI-11-0634. View

19.

Cella D, Jensen S, Webster K, Hongyan D, Lai J, Rosen S . Measuring health-related quality of life in leukemia: the Functional Assessment of Cancer Therapy--Leukemia (FACT-Leu) questionnaire. Value Health. 2012; 15(8):1051-8. DOI: 10.1016/j.jval.2012.08.2210. View

20.

Schuler M, Hentschel L, Gobel J, Balaian E, Hornemann B, Hoffmann J . Effects of a home-based exercise program on physical capacity and fatigue in patients with low to intermediate risk myelodysplastic syndrome-a pilot study. Leuk Res. 2016; 47:128-35. DOI: 10.1016/j.leukres.2016.05.022. View